Skip to main navigation Skip to search Skip to main content

The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials

J. S. Kirby*, L. Thorlacius, B. Villumsen, J. R. Ingram, A. Garg, K. B. Christensen, M. Butt, S. Esmann, J. Tan, G. B.E. Jemec

*Corresponding author for this work
103 Citations (Scopus)

Abstract

Background: Hidradenitis suppurativa (HS) is a chronic, inflammatory condition that can have a large negative impact on health-related quality of life (HRQOL). A reliable and validated measure of HS-specific HRQOL in clinical studies is needed.

Original languageEnglish
JournalBritish Journal of Dermatology
Volume183
Issue number2
Pages (from-to)340-348
Number of pages9
ISSN0007-0963
DOIs
Publication statusPublished - 1 Aug 2020
Externally publishedYes

Fingerprint

Dive into the research topics of 'The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials'. Together they form a unique fingerprint.

Cite this